Drs. Rafael Bejar (San Diego) and Moshe Mittelman (Tel Aviv) discuss several papers highlighting the role of genetics in MDS diagnosis, follow up and prediction of treatment. They also discuss the role of the newly approved luspatercept in the treatment of anemic transfusion-dependent patients with lower-risk MDS

The role of genetics in MDS management [MDS Professional Report]

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.<br />The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Medicine

Health & Fitness

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research.<br>The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.

Share The role of genetics in MDS management [MDS Professional Report]

Sign up to save your podcasts

The role of genetics in MDS management [MDS Professional Report]

The role of genetics in MDS management [MDS Professional Report]

More shows like MDS Professional Report

The Mel Robbins Podcast